Indium In-111 ibritumomab tiuxetan

DB32138ApprovedProtein Based Therapies

Indium In-111 ibritumomab tiuxetan: Overview.

Mechanism
Curator reviewed
Also known as
111indium-zevalin · Ibritumomab Tiuxetan In-111 · Ibritumomab Tiuxetan Indium In-111 · Indium in 111 Ibritumomab Tiuxetan · Zevalin In-111

Resolves to

Compound
UNIIS9U4ZR2W8V
Targets
P11836MS4A1

What you can answer from here — as of February 11, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Indium In-111 ibritumomab tiuxetan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In